CLAVYQAGA-Arg(13C6,15N4) TFA_product_DataBase

Bioactivity	CLAVYQAGA-Arg(13C6, 15N4) TFA is a peptide containing 13C6 and 15N4 labeled Arg[1].
Invitro	氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> CLAVYQAGA-Arg(13C6,15N4) TFA 相关抗体:
Sequence	Cys-Leu-Ala-Val-Tyr-Gln-Ala-Gly-Ala-Arg(13C6,15N4)
Shortening	CLAVYQAGA-Arg(13C6,15N4)
Formula	C3913C6H74N1015N4O13S.xC2HF3O2
Molar Mass	1061.15 (free base)
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

PeptideDB